Table 1.
Potential role of m6A regulators in different cancers
Cancer | m6A regulators | Related genes | Potential Role | Ref. |
---|---|---|---|---|
AML | METTLE3 | C-MYC and BCL2 | Oncogene | [28] |
METTLE14 | MYB, MYC | Oncogene | [29] | |
WTAP | N | Oncogene | [33] | |
Cervical cancer | METTL3/METTL14 | N | Tumor-suppressor | [30] |
FTO/ALKBH5 | N | Oncogene | [30] | |
Breast cancer | ALKBH5 | NANOG | Oncogene | [39] |
Colorectal cancer | YTHDF1 | Associated with c-Myc | Oncogene | [52] |
Glioblastoma | METTL3/METTL14 | ADAM19 | Tumor-suppressor | [27] |
ALKBH5 | FOXM1 | Oncogene | [38] | |
HCC | METTLE14 | miR126 | Tumor-suppressor | [34] |
YTHDF2 | Associated with miR-145 | Oncogene | [53] | |
Lung cancer | METTLE3 | EGFR, TAZ, DNMT3A | Oncogene | [25] |
MLL-rearranged AML | FTO | ASB2, RARA | Oncogene | [36,37] |
Renal cell carcinoma | METTL3 | PI3K-Akt-mTOR pathways | Tumor-suppressor | [31] |
WTAP | Associated with CDK2 | Oncogene | [34] |
Note: N means there are no known relevant genes in this review.